{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:36:08Z","timestamp":1759332968722,"version":"3.44.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.annder.2016.06.012","type":"journal-article","created":{"date-parts":[[2016,8,6]],"date-time":"2016-08-06T02:09:41Z","timestamp":1470449381000},"page":"113-120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Syndrome d\u2019enc\u00e9phalopathie post\u00e9rieure r\u00e9versible au cours d\u2019une granulomatose avec polyang\u00e9ite"],"prefix":"10.1016","volume":"144","author":[{"given":"L.","family":"Chaput","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Rabot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Limousin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-P.","family":"Cottier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Lioger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Samimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2016.06.012_bib0155","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJM199602223340803","article-title":"A reversible posterior leukoencephalopathy syndrome","volume":"334","author":"Hinchey","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annder.2016.06.012_bib0160","doi-asserted-by":"crossref","first-page":"427","DOI":"10.4065\/mcp.2009.0590","article-title":"Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings","volume":"85","author":"Fugate","year":"2010","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.annder.2016.06.012_bib0165","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.3174\/ajnr.A0549","article-title":"Distinct imaging patterns and lesion distribution in posterior reversible encephalopathy syndrome","volume":"28","author":"Bartynski","year":"2007","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.annder.2016.06.012_bib0170","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.clineuro.2011.12.008","article-title":"Posterior reversible encephalopathy syndrome and oral methotrexate","volume":"114","author":"Hart","year":"2012","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.annder.2016.06.012_bib0175","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1001\/archdermatol.2011.161","article-title":"Reversible posterior leukoencephalopathy syndrome in a patient treated with ustekinumab: case report and review of the literature","volume":"147","author":"Gratton","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2016.06.012_bib0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajem.2009.04.019","article-title":"Reversible posterior leukoencephalopathy syndrome after rituximab","volume":"28","author":"Zito","year":"2010","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.annder.2016.06.012_bib0185","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s00415-008-0732-y","article-title":"TNF-antagonist etanercept induced reversible posterior leukoencephalopathy syndrome","volume":"255","author":"Kastrup","year":"2008","journal-title":"J Neurol"},{"key":"10.1016\/j.annder.2016.06.012_bib0190","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.hemonc.2013.05.002","article-title":"Cyclosporine-related posterior reversible encephalopathy syndrome after cord blood stem cell transplantation","volume":"6","author":"Jennane","year":"2013","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"10.1016\/j.annder.2016.06.012_bib0195","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1186\/1752-1947-8-442","article-title":"Cyclophosphamide-induced posterior reversible encephalopathy syndrome (PRES): a case report","volume":"8","author":"Jayaweera","year":"2014","journal-title":"J Med Case Rep"},{"key":"10.1016\/j.annder.2016.06.012_bib0200","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10072-008-0929-y","article-title":"A case of posterior reversible encephalopathy during polyarteritis nodosa vasculitis","volume":"29","author":"Stanzani","year":"2008","journal-title":"Neurol Sci"},{"key":"10.1016\/j.annder.2016.06.012_bib0205","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.pediatrneurol.2011.10.006","article-title":"Henoch-Sch\u00f6nlein purpura with posterior reversible encephalopathy syndrome","volume":"46","author":"Dasarathi","year":"2012","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.annder.2016.06.012_bib0210","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.arcped.2008.12.014","article-title":"Enc\u00e9phalopathie post\u00e9rieure r\u00e9versible compliquant un purpura rhumato\u00efde\u00a0: pr\u00e9sentation d\u2019un cas","volume":"16","author":"Salloum","year":"2009","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.annder.2016.06.012_bib0215","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s10067-012-2151-9","article-title":"Takayasu's arteritis and posterior reversible encephalopathy syndrome: a case-based review","volume":"32","author":"Camara-Lemarroy","year":"2013","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.annder.2016.06.012_bib0220","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4103\/0972-2327.85900","article-title":"Unusual presentation of Takayasu's arteritis as posterior reversible encephalopathy syndrome","volume":"14","author":"Zaki","year":"2011","journal-title":"Ann Indian Acad Neurol"},{"key":"10.1016\/j.annder.2016.06.012_bib0225","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1007\/s00296-015-3261-x","article-title":"Eosinophilic granulomatosis with polyangiitis (EGPA) and PRES: a case-based review of literature in ANCA-associated vasculitides","volume":"35","author":"Marra","year":"2015","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.annder.2016.06.012_bib0230","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s00467-003-1286-y","article-title":"Reversible posterior leukoencephalopathy in a patient with Wegener granulomatosis","volume":"19","author":"Ohta","year":"2004","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.annder.2016.06.012_bib0235","doi-asserted-by":"crossref","first-page":"567","DOI":"10.5692\/clinicalneurol.52.567","article-title":"[Reversible posterior leukoencephalopathy syndrome (RPLS) associated with Wegener's granulomatosis: a case report and review of the literature]","volume":"52","author":"Onozawa","year":"2012","journal-title":"Rinsh\u014d Shinkeigaku"},{"key":"10.1016\/j.annder.2016.06.012_bib0240","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1212\/01.wnl.0000339489.16519.17","article-title":"Clinical reasoning: a case of Wegener granulomatosis complicated by seizures and headaches: curiouser and curiouser","volume":"72","author":"Gorman","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.annder.2016.06.012_bib0245","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3109\/s10165-008-0052-1","article-title":"Reversible posterior leukoencephalopathy syndrome: a possible manifestation of Wegener's granulomatosis-mediated endothelial injury","volume":"18","author":"Nishio","year":"2008","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.annder.2016.06.012_bib0250","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1007\/s00296-010-1367-8","article-title":"Posterior reversible encephalopathy syndrome in a patient with ANCA-associated vasculitis","volume":"32","author":"Fuentes","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.annder.2016.06.012_bib0255","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/ard.60.5.534","article-title":"Reversible posterior leucoencephalopathy syndrome in systemic lupus and vasculitis","volume":"60","author":"Primavera","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.annder.2016.06.012_bib0260","first-page":"7","article-title":"Posterior reversible encephalopathy syndrome and systemic vasculitis: report of six cases","volume":"34","author":"Lioger","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.annder.2016.06.012_bib0265","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1007\/s00134-003-1901-1","article-title":"Posterior reversible encephalopathy syndrome (PRES) in critically ill obstetric patients","volume":"29","author":"Servillo","year":"2003","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.annder.2016.06.012_bib0270","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0887-8994(01)00265-X","article-title":"Clinical spectrum of reversible posterior leukoencephalopathy syndrome","volume":"24","author":"Kwon","year":"2001","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.annder.2016.06.012_bib0275","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0887-8994(98)00148-9","article-title":"Posterior leukoencephalopathy syndrome may not be reversible","volume":"20","author":"Antunes","year":"1999","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.annder.2016.06.012_bib0280","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.3174\/ajnr.A0929","article-title":"Posterior reversible encephalopathy syndrome, part\u00a02: controversies surrounding pathophysiology of vasogenic edema","volume":"29","author":"Bartynski","year":"2008","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.annder.2016.06.012_bib0285","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/1756-185X.12148","article-title":"Posterior reversible encephalopathy syndrome in systemic lupus erythematosus following methylprednisolone: report of two cases","volume":"16","author":"Chennareddy","year":"2013","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.annder.2016.06.012_bib0290","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.clineuro.2014.06.034","article-title":"Management and outcomes of malignant posterior reversible encephalopathy syndrome","volume":"125","author":"Akins","year":"2014","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.annder.2016.06.012_bib0295","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1002\/acr.22047","article-title":"Clinical features and outcomes of posterior reversible encephalopathy syndrome in patients with systemic lupus erythematosus","volume":"65","author":"Lai","year":"2013","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.annder.2016.06.012_bib0150","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1177\/0961203313496341","article-title":"Posterior reversible encephalopathy syndrome in Korean patients with systemic lupus erythematosus: risk factors and clinical outcome","volume":"22","author":"Jung","year":"2013","journal-title":"Lupus"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963816303404?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963816303404?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T11:04:49Z","timestamp":1758971089000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963816303404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S0151963816303404"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2016.06.012","relation":{},"ISSN":["0151-9638"],"issn-type":[{"type":"print","value":"0151-9638"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Syndrome d\u2019enc\u00e9phalopathie post\u00e9rieure r\u00e9versible au cours d\u2019une granulomatose avec polyang\u00e9ite","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2016.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}